Disparities in Utilization of Immune Checkpoint Inhibitor Therapy Among Older Patients With Advanced Non–Small Cell Lung Cancer: A SEER-Medicare Analysis
NH-Black patients with aNSCLC were less likely to receive ICI therapy than their NH-White counterparts. Our findings indicate the racial/ethnic disparities in ICI therapy utilization and call for further interventions to optimize access to care.
Authors
- Hyung‐Suk Yoon (ORCID: https://orcid.org/0000-0001-6368-2684)
- Estelamari Rodríguez (ORCID: https://orcid.org/0000-0001-8132-4573)
- Jiang Bian (ORCID: https://orcid.org/0000-0002-2238-5429)
- Dejana Braithwaite (ORCID: https://orcid.org/0000-0001-8376-5903)
- Shama D. Karanth (ORCID: https://orcid.org/0000-0001-5371-6908)
- Xiwei Lou
- Lusine Yaghjyan (ORCID: https://orcid.org/0000-0002-1626-5340)
- Hiren J. Mehta (ORCID: https://orcid.org/0000-0001-7331-747X)
- Yi Guo (ORCID: https://orcid.org/0000-0003-0587-4105)
- Tomi Akinyemiju (ORCID: https://orcid.org/0000-0002-1412-3234)
- Danting Yang (ORCID: https://orcid.org/0000-0002-0097-8581)
- Dongyu Zhang (ORCID: https://orcid.org/0000-0002-7845-4630)
- Jae Jeong Yang
Institutions
- Johnson & Johnson (United States) (US)
- University of Miami (US)
- Duke University (US)
- University of Florida Health (US)
- University of Florida (US)
- Sylvester Comprehensive Cancer Center (US)
- UF Health Cancer Center
- Florida College (US)
Publication Details
- Journal
- JCO oncology advances.
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1200/oa.24.00008
- Citations
- 3
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 1.26